CAREERS

Abbott CRM strive to be the first choice for implantable device therapies in Heart Failure & Rhythm Management. We do this by working in partnership with healthcare providers, focusing on improving clinical outcomes and experience for patients.

Within our Rapid Diagnostics division, our Cardiometabolics and Informatics business unit is transforming care by giving people — and their doctors — timely information to better manage health. We offer chronic care management testing in multiple settings. Our products provide highly accurate test results during the patient consultation, using only a tiny fingerstick or urine sample. The immediate test results provide physicians and patients with the critical information needed to make better decisions for the diagnosis and management of cardiovascular disease, diabetes and their comorbidities.

We're transforming the treatment of vascular disease through next-generation devices, investments in research and development, and educational resources for healthcare professionals. Our products make better health outcomes possible every day - from industry-leading drug-eluting stents to minimally invasive treatments that help speed recovery with fewer complications.

We're committed to creating innovative technologies that help people with diabetes better manage their conditions. Our state-of-the-art blood glucose meters provide fast, accurate results and make testing more comfortable. For healthcare professionals, we offer point-of-care hand-held devices that provide fast, accurate results of glucose or beta-ketone levels, help minimize user errors and increase efficiency.

In the multifaceted landscape of cardiac electrophysiology, we strive to deliver improved patient outcomes by providing physicians, nurses and allied health professionals with innovative products and class leading clinical support and education. We produce the most comprehensive portfolio of diagnostic and radiofrequency ablation tools and offer a precise and flexible 3-D mapping platform, Ensite Precision, with which to treat the full spectrum of cardiac arrhythmias.

Heart failure results in a large burden on the NHS, accounting for around one million inpatient beddays – 2% of the NHS total – and 5% of all emergency hospital admissions. Abbott’s heart failure portfolio includes the CardioMEMS implantable pressure sensor which aims to give physicians more information about patient heart function to prevent hospitalisations, and ventricular assist devices; blood pumps which take over the function of the heart in the most sick patients.

Our infectious disease diagnostic tests and monitoring devices provide results for over 75 types of infectious diseases, including those caused by bacteria, viruses, fungi or parasites.

Lingo our new consumer biowearable provides users with a window into their body. Lingo tracks key biomarkers – such as glucose, empowering people to make better decisions about their health and nutrition. Biowearable technology will digitise, decentralise and democratise healthcare.

Neuromodulation tackles major clinical diseases including chronic pain and movement disorders through next-generation medical device advances. It's our mission to improve quality of life and help people live fuller, more active lives. Our investment in clinical trials redefines clinical pathways, putting entirely new treatment modalities into the hands of physicians with the latest wireless Apple programming platforms.

We understand that good nutrition provides the foundation for a lifetime of good health. That's why we develop a variety of science-based products that nourish infants, children and adults - from oral nutritional supplements to tube feeds. We also offer a variety of resources for patients, caregivers and healthcare professionals, including a free nutrition helpline, as well as a service devoted to easing the transition from hospital to home.

The Structural Heart division's mission is to help people live better lives through better health by restoring health and improving quality of life through the design and development of device and management solutions for the treatment of structural heart disease. We provide leading therapies in key segments - structural heart occlusion, surgical valves and transcatheter valve therapies.

Our innovative technology, industry experts and insightful data provide comprehensive drug-testing answers, empowering confident decision making. Our goal is to accelerate and expand our global market leadership in Toxicology and Occupational Health Screening by providing customer centric, innovative and comprehensive testing services.